• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年大鼠脑缺血后自体骨髓静脉注射的治疗窗。

A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.

作者信息

Iihoshi Satoshi, Honmou Osamu, Houkin Kiyohiro, Hashi Kazuo, Kocsis Jeffery D

机构信息

Department of Neurosurgery, Sapporo Medical University School of Medicine, Sapporo, South-1st, West-16th, Chuo, Sapporo, Hokkaido 060-8543, Japan.

出版信息

Brain Res. 2004 May 8;1007(1-2):1-9. doi: 10.1016/j.brainres.2003.09.084.

DOI:10.1016/j.brainres.2003.09.084
PMID:15064130
Abstract

The primary objective of this study was to test the hypothesis that intravenous administration of autologous bone marrow cells could improve functional recovery after middle cerebral artery occlusion (MCAO) for 45 min in the rat and to determine specific time windows for efficacy. Mononuclear cells from autologous bone marrow were transfected with the LacZ reporter gene, and injected intravenously into rats at 3-72 h after induction of MCAO. Histological analysis of the ischemic lesion at 14 days after transplantation revealed reduced ischemic lesion volume. Lesion volume was 250+/-45 mm(3) (n=6) after MCAO without cell transplantation. Lesions were minimally detected by absence of 2,3,5-triphenyltetrazolium chloride (TTC) staining when bone marrow cells were infused 3 h after lesion induction. Lesions were clearly detected beginning with the 6-h postlesion group and became progressively larger at 12, 24 and 72 h (80+/-25, 140+/-18, and 180+/-22 mm(3), respectively; n=6 for each group). Transplanted LacZ(+) bone marrow cells accumulated extensively in and around the ischemic lesions, and immunohistochemistry suggests some neuronal and glial lineage differentiation. Behavioral testing (Morris water maze and Treadmill stress test) indicated greater functional recovery in the treated group. These findings suggest that early intervention with intravenous administration of autologous mononuclear cells from bone marrow can reduce lesion size in the MCAO model in the rat, and improve functional outcome.

摘要

本研究的主要目的是验证以下假设

静脉注射自体骨髓细胞可改善大鼠大脑中动脉闭塞(MCAO)45分钟后的功能恢复,并确定有效的特定时间窗。将来自自体骨髓的单核细胞用LacZ报告基因转染,并在MCAO诱导后3至72小时静脉注射到大鼠体内。移植后14天对缺血性病变进行组织学分析,结果显示缺血性病变体积减小。未进行细胞移植的MCAO大鼠,病变体积为250±45立方毫米(n = 6)。在病变诱导后3小时注入骨髓细胞时,通过2,3,5-三苯基四氮唑氯化物(TTC)染色未检测到明显病变。从病变后6小时组开始可清晰检测到病变,且在12、24和72小时时病变逐渐增大(分别为80±25、140±18和180±22立方毫米;每组n = 6)。移植的LacZ(+)骨髓细胞在缺血性病变及其周围大量聚集,免疫组织化学表明有一些神经元和神经胶质谱系分化。行为测试(莫里斯水迷宫和跑步机应激测试)表明治疗组的功能恢复更好。这些发现表明,早期通过静脉注射自体骨髓单核细胞进行干预可减小大鼠MCAO模型中的病变大小,并改善功能结局。

相似文献

1
A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.成年大鼠脑缺血后自体骨髓静脉注射的治疗窗。
Brain Res. 2004 May 8;1007(1-2):1-9. doi: 10.1016/j.brainres.2003.09.084.
2
Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.静脉输注永生化人骨髓间充质干细胞可保护成年大鼠脑缺血模型免受损伤。
Exp Neurol. 2006 May;199(1):56-66. doi: 10.1016/j.expneurol.2005.05.004. Epub 2005 Jun 20.
3
Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia.人神经干细胞可改善成年大鼠脑实验性局灶性缺血后的感觉运动功能障碍。
Brain Res. 2004 Aug 6;1016(2):145-53. doi: 10.1016/j.brainres.2004.04.038.
4
Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.静脉注射骨髓基质细胞疗法可减少雌性大鼠中风后的细胞凋亡并促进内源性细胞增殖。
J Neurosci Res. 2003 Sep 15;73(6):778-86. doi: 10.1002/jnr.10691.
5
Bone marrow stromal cells upregulate expression of bone morphogenetic proteins 2 and 4, gap junction protein connexin-43 and synaptophysin after stroke in rats.大鼠中风后骨髓基质细胞上调骨形态发生蛋白2和4、缝隙连接蛋白连接蛋白43以及突触素的表达。
Neuroscience. 2006 Aug 25;141(2):687-695. doi: 10.1016/j.neuroscience.2006.04.054. Epub 2006 May 30.
6
Bone mesenchymal stem cells transplantation combined with mild hypothermia improves the prognosis of cerebral ischemia in rats.骨髓间充质干细胞移植联合亚低温改善脑缺血大鼠预后。
PLoS One. 2018 Aug 1;13(8):e0197405. doi: 10.1371/journal.pone.0197405. eCollection 2018.
7
Neuroprotective effects of intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats on ischemic stroke.5-氟尿嘧啶预处理大鼠骨髓单个核细胞静脉移植对缺血性脑卒中的神经保护作用
Behav Brain Res. 2016 Mar 15;301:287-92. doi: 10.1016/j.bbr.2015.07.048. Epub 2015 Jul 26.
8
Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.静脉注射胶质细胞源性神经营养因子基因修饰的人骨髓间充质干细胞可保护成年大鼠脑缺血模型免受损伤。
J Neurosci Res. 2006 Nov 15;84(7):1495-504. doi: 10.1002/jnr.21056.
9
Intracerebral transplantation of bone marrow with BDNF after MCAo in rat.
Neuropharmacology. 2000 Mar 3;39(5):711-6. doi: 10.1016/s0028-3908(00)00006-x.
10
Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke.自体骨髓单核细胞治疗缺血性脑卒中的治疗时间窗和剂量反应。
J Neurosci Res. 2011 Jun;89(6):833-9. doi: 10.1002/jnr.22614. Epub 2011 Mar 15.

引用本文的文献

1
Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients-A randomized, open-label, controlled phase II clinical trial.颅内动脉输注循环衍生自体 CD34+细胞治疗急性缺血性脑卒中患者的长期转归:一项随机、开放标签、对照的 II 期临床试验。
Stem Cell Res Ther. 2024 Nov 20;15(1):443. doi: 10.1186/s13287-024-04021-7.
2
Therapeutic Applications of Engineered Mesenchymal Stromal Cells for Enhanced Angiogenesis in Cardiac and Cerebral Ischemia.工程化间充质基质细胞在心脏和脑缺血中增强血管生成的治疗应用。
Stem Cell Rev Rep. 2024 Nov;20(8):2138-2154. doi: 10.1007/s12015-024-10787-3. Epub 2024 Sep 21.
3
Mononuclear cell therapy of neonatal hypoxic-ischemic encephalopathy in preclinical versus clinical studies: a systematic analysis of therapeutic efficacy and study design.
新生儿缺氧缺血性脑病单核细胞治疗的临床前与临床研究:治疗效果及研究设计的系统分析
Neuroprotection. 2023 Dec;1(2):143-159. doi: 10.1002/nep3.29. Epub 2023 Dec 30.
4
Human placenta-derived mesenchymal stem cells stimulate neuronal regeneration by promoting axon growth and restoring neuronal activity.人胎盘间充质干细胞通过促进轴突生长和恢复神经元活性来刺激神经元再生。
Front Cell Dev Biol. 2023 Dec 22;11:1328261. doi: 10.3389/fcell.2023.1328261. eCollection 2023.
5
Neuroprotection of Stem Cells Against Ischemic Brain Injury: From Bench to Clinic.干细胞对缺血性脑损伤的神经保护作用:从基础到临床。
Transl Stroke Res. 2024 Aug;15(4):691-713. doi: 10.1007/s12975-023-01163-3. Epub 2023 Jul 7.
6
Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.缺血性脑卒中的神经保护策略——未来展望。
Int J Mol Sci. 2023 Feb 22;24(5):4334. doi: 10.3390/ijms24054334.
7
Ischemic Brain Stroke and Mesenchymal Stem Cells: An Overview of Molecular Mechanisms and Therapeutic Potential.缺血性脑卒中和间充质干细胞:分子机制与治疗潜力概述
Stem Cells Int. 2022 May 25;2022:5930244. doi: 10.1155/2022/5930244. eCollection 2022.
8
Strategies to Improve the Quality and Freshness of Human Bone Marrow-Derived Mesenchymal Stem Cells for Neurological Diseases.提高用于神经疾病的人骨髓间充质干细胞质量和新鲜度的策略
Stem Cells Int. 2021 Sep 8;2021:8444599. doi: 10.1155/2021/8444599. eCollection 2021.
9
Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion.线粒体在细胞死亡和炎症中的不同作用:聚焦缺血性中风和再灌注中的线粒体质量控制
Biomedicines. 2021 Feb 9;9(2):169. doi: 10.3390/biomedicines9020169.
10
Intravenous Bone Marrow Mononuclear Cells Transplantation Improves the Effect of Training in Chronic Stroke Mice.静脉注射骨髓单个核细胞移植可改善慢性中风小鼠的训练效果。
Front Med (Lausanne). 2020 Nov 26;7:535902. doi: 10.3389/fmed.2020.535902. eCollection 2020.